LifeStance Health GroupLFST +2.22%57 Current Ratio is 1.48 as of Mar. 2026, which is 8% above its 10-year median of 1.37. GuruFocus rates LFST with a GF Score™ of 57/100 and a GF Value™ of $8.22 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 683 Healthcare Providers & Services companies, LifeStance Health Group ranks better than 50.81% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. LifeStance Health Group's current ratio for the quarter that ended in Mar. 2026 was 1.48.
LifeStance Health Group has a current ratio of 1.48. It generally indicates good short-term financial strength.
The historical rank and industry rank for LifeStance Health Group's Current Ratio or its related term are showing as below:
LFST'
s Current Ratio Range Over the Past 10 Years
Min: 0.5 Med: 1.37 Max: 3.23
Current: 1.48
During the past 7 years, LifeStance Health Group's highest Current Ratio was 3.23. The lowest was 0.50. And the median was 1.37.
LFST's Current Ratio is ranked better than 50.81% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs LFST: 1.48
LifeStance Health Group (NAS:LFST) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
LifeStance Health Group Current Ratio Related Terms
LifeStance Health Group Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, LifeStance Health Group's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeStance Health Group Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's Current Ratio distribution charts can be found below:
* The bar in red indicates where LifeStance Health Group's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeStance Health Group (LFST) has a Current Ratio of 1.48 as of Mar. 2026. This is near median its historical median of 1.37. Over the past decade, LifeStance Health Group's Current Ratio has ranged from 0.50 to 3.23. According to the industry distribution chart, LifeStance Health Group ranks #336 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 49.2%.
Is LifeStance Health Group's Current Ratio too high?
LifeStance Health Group's current Current Ratio of 1.48 is near median its 10-year median of 1.37. Over the past 10 years, this metric has ranged from a low of 0.50 to a high of 3.23. The Healthcare Providers & Services industry median Current Ratio is 1.47. LifeStance Health Group's value of 1.48 is 0.7% above this industry median. Based on the distribution chart, LifeStance Health Group ranks #336 out of 683 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, LifeStance Health Group has a GF Score™ of 57/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's Current Ratio compare to NHC and BKD?
According to the Healthcare Providers & Services industry distribution chart, LifeStance Health Group ranks #336 out of 683 companies for Current Ratio. This puts LifeStance Health Group in the upper half of its industry. The industry median Current Ratio is 1.47. LifeStance Health Group's value of 1.48 is 0.7% above this benchmark. Historically, LifeStance Health Group's own Current Ratio has ranged from 0.50 to 3.23 over the past decade. While the company's 10-year median is 1.37 vs. the industry median of 1.47, LifeStance Health Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeStance Health Group's current Current Ratio of 1.48 is 0.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeStance Health Group's current Current Ratio is 1.48, which is near median its own 10-year median of 1.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.22, compared to a current price of $9.65 — trading 17.4% above its estimated fair value. The current Current Ratio is 1.48, which is near median its 10-year median of 1.37 and 0.7% above the Healthcare Providers & Services industry median of 1.47. LifeStance Health Group's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current Current Ratio is 1.48 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeStance Health Group (LFST) Overvalued in 2026?
Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued.
The current stock price of $9.65 is trading 17.4% above its estimated GF Value™ of $8.22.
GuruFocus considers LifeStance Health Group to be Modestly Overvalued.
Key valuation signals for LFST:
Current Ratio: 1.48 (near median its 10-year median of 1.37)
GF Value™: $8.22 vs. price of $9.65 (17.4% above fair value)
Industry Position: 0.7% above the Healthcare Providers & Services median (#336 of 683)
No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
57GF Score
Get the complete analysis for LFST
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFST has been successfully added to your 
